A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass - Avidan,M.S.; Levy,J.H.; Scholz,J. (Anesthesiology, 2005)